These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 12169296)
1. Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders. Pralong E; Magistretti P; Stoop R Prog Neurobiol; 2002 Jun; 67(3):173-202. PubMed ID: 12169296 [TBL] [Abstract][Full Text] [Related]
2. The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Joyce JN Psychopharmacology (Berl); 1993; 112(1 Suppl):S16-34. PubMed ID: 7831438 [TBL] [Abstract][Full Text] [Related]
3. Limbic circuits and monoamine receptors: dissecting the effects of antipsychotics from disease processes. Joyce JN; Goldsmith SG; Gurevich EV J Psychiatr Res; 1997; 31(2):197-217. PubMed ID: 9278186 [TBL] [Abstract][Full Text] [Related]
4. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia. Csernansky JG; Bardgett ME Schizophr Bull; 1998; 24(2):231-48. PubMed ID: 9613623 [TBL] [Abstract][Full Text] [Related]
5. Novel targets for drugs in schizophrenia. Stone JM; Pilowsky LS CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):265-72. PubMed ID: 17691983 [TBL] [Abstract][Full Text] [Related]
6. The neurobiology of schizophrenia. Littrell RA; Schneiderhan M Pharmacotherapy; 1996; 16(6 Pt 2):143S-147S; discussion 166S-168S. PubMed ID: 8947997 [TBL] [Abstract][Full Text] [Related]
7. Transmitter dysfunction during the process of schizophrenia. Glenthøj BY; Hemmingsen R Acta Psychiatr Scand Suppl; 1999; 395():105-12. PubMed ID: 10225339 [TBL] [Abstract][Full Text] [Related]
8. Monoamines and schizophrenia. Sedvall G Acta Psychiatr Scand Suppl; 1990; 358():7-13. PubMed ID: 1978495 [TBL] [Abstract][Full Text] [Related]
9. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders. Wood MD; Wren PB Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035 [TBL] [Abstract][Full Text] [Related]
10. The role of glutamate receptors and their interactions with dopamine and other neurotransmitters in the development of tardive dyskinesia: preclinical and clinical results. Szota AM; Scheel-Krüger J Behav Pharmacol; 2020 Sep; 31(6):511-523. PubMed ID: 32459694 [TBL] [Abstract][Full Text] [Related]
11. [Involvement of central neurotransmission systems in schizophrenia]. Martres MP Therapie; 2008; 63(3):177-85. PubMed ID: 18718209 [TBL] [Abstract][Full Text] [Related]
12. In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin. Clinckers R; Gheuens S; Smolders I; Meurs A; Ebinger G; Michotte Y Epilepsia; 2005 Jun; 46(6):828-36. PubMed ID: 15946324 [TBL] [Abstract][Full Text] [Related]
13. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Rebec GV; Pierce RC Prog Neurobiol; 1994 Aug; 43(6):537-65. PubMed ID: 7816935 [TBL] [Abstract][Full Text] [Related]
15. Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex. López-Gil X; Artigas F; Adell A Curr Pharm Des; 2010; 16(5):502-15. PubMed ID: 19909228 [TBL] [Abstract][Full Text] [Related]
16. From arousal to cognition: the integrative position of the prefrontal cortex. Robbins TW Prog Brain Res; 2000; 126():469-83. PubMed ID: 11105663 [No Abstract] [Full Text] [Related]
17. [Neurotransmission in developmental disorders]. Takeuchi Y No To Hattatsu; 2008 Nov; 40(6):451-5. PubMed ID: 19039985 [TBL] [Abstract][Full Text] [Related]
18. Role of central glutamatergic neurotransmission in the pathogenesis of psychiatric and behavioral disorders. Wang SJ; Yang TT Drug News Perspect; 2005 Nov; 18(9):561-6. PubMed ID: 16421629 [TBL] [Abstract][Full Text] [Related]
19. Biochemical basis of analgesia: metabolism, storage, regulation, and action. Greenberg S; Palmer GC Dent Clin North Am; 1978 Jan; 22(1):31-46. PubMed ID: 23327 [No Abstract] [Full Text] [Related]
20. Glutamatergic mechanisms in schizophrenia. Tsai G; Coyle JT Annu Rev Pharmacol Toxicol; 2002; 42():165-79. PubMed ID: 11807169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]